awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36804518-EBB70877-D7BC-4111-A218-B527F9ABE8C2
Q36804518-EBB70877-D7BC-4111-A218-B527F9ABE8C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36804518-EBB70877-D7BC-4111-A218-B527F9ABE8C2
Antiangiogenic therapies for advanced hepatocellular carcinoma.
P2860
Q36804518-EBB70877-D7BC-4111-A218-B527F9ABE8C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36804518-EBB70877-D7BC-4111-A218-B527F9ABE8C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d35b6c745b069fc9aeb5a9c5f171101d98fa268
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.